Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.6 USD | +0.07% | -0.15% | +3.61% |
09:44am | Medincell: share price rises on resumption of trading | CF |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
ETFs positioned on AbbVie Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.54% | 12 M€ | +15.09% | - | |
1.45% | 0 M€ | +8.51% | ||
1.39% | 2 M€ | +21.73% | - | |
1.35% | 219 M€ | +17.17% | - | |
1.35% | 1,448 M€ | -.--% | - | |
1.34% | 330 M€ | -.--% | - | |
1.30% | 0 M€ | +7.94% | - | |
1.30% | 0 M€ | +5.05% | ||
1.18% | 273 M€ | -.--% | ||
1.18% | 655 M€ | -.--% | - | |
1.18% | 1,174 M€ | +23.54% | ||
1.16% | 0 M€ | +3.47% | - | |
1.16% | 0 M€ | -0.30% | - | |
1.16% | 0 M€ | -0.73% | - | |
1.06% | 0 M€ | +7.52% | ||
1.02% | 0 M€ | +18.44% | - | |
1.00% | 276 M€ | +11.40% | - | |
0.96% | 1 M€ | +0.04% | ||
0.94% | 1,848 M€ | +18.39% | - | |
0.94% | 559 M€ | +14.30% | - | |
0.91% | 204 M€ | +10.54% | ||
0.90% | 6 M€ | +17.98% | - | |
0.89% | 0 M€ | +6.45% | - | |
0.81% | 0 M€ | +8.05% | ||
0.81% | 0 M€ | +4.95% | - | |
0.78% | 0 M€ | +5.36% | - | |
0.74% | 0 M€ | +9.11% | ||
0.73% | 205 M€ | -.--% | ||
0.72% | 0 M€ | +7.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.61% | 283B | |
+32.88% | 698B | |
+26.51% | 568B | |
-4.48% | 358B | |
+19.30% | 328B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.57% | 165B | |
-2.56% | 160B |
- Stock Market
- Equities
- ABBV Stock
- Funds and ETFs AbbVie Inc.